Results 191 to 200 of about 12,580 (255)

Continuity of eastern Beringian megafauna phylogenetic diversity following deposition of the Late Pleistocene Dawson tephra. [PDF]

Arct Antarct Alp Res
Wanket C, Cocker SL, De Sanctis B, Oliveira M, Bond J, Jensen BJL, Froese DG, Shapiro B.   +7 more
europepmc   +1 more source

Endangered Deep-Snow Mountain Caribou Have a Distinct Winter Diet and Gut Microbiome That May Be Altered by Maternal Penning. [PDF]

Mol Ecol
Sugden S, Serrouya R, Neufeld L, Schwantje H, St Clair CC, Stein L, Spribille T.   +6 more
europepmc   +1 more source

Emulation or Degradation? Evaluating Forest Management Outcomes in Boreal Northeastern Ontario. [PDF]

Environ Manage
Malcolm JR, Boan JJ, Ray JC.
europepmc   +1 more source

Every wrinkle holds a thousand tales: reflections from the North. [PDF]

CMAJ
Móráin CÓ.
europepmc   +1 more source

Caribou Island Seeds, 1938

, 1938
Henry G. Gilbert Nursery and Seed Trade Catalog Collection., Caribou Island Seeds.   +1 more
core  

Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival. [PDF]

Transplant Cell Ther
Kaur G, Logue J, Brazauskas R, Oloyede T, Abid MB, Ahmed S, Aljurf M, Banerjee R, Bashey A, Beitinjaneh AM, Callander NS, Castillo P, Dholaria B, Goldsmith SR, Hashmi S, Kharfan-Dabaja MA, Liu H, Mian H, Nishihori T, Rejeski K, Saad A, Slade MJ, Turtle CJ, Vogl DT, Williams KM, Wirk B, Pasquini MC, Moskop A, Akhtar OS, Hansen DK, Janakiram M.   +30 more
europepmc   +1 more source

Early mortality with bispecific antibody therapy in RRMM: an IMWG immunotherapy database real-world analysis. [PDF]

Blood Adv
Tan CR, Usmani S, Derkach A, de Meneze Silva Corraes A, Parrondo R, Ailawadhi S, Asoori S, Dave M, Popat R, Morjaria O, Hajek R, Mihalyova J, Htut M, Janakiram M, Visram A, Kastritis E, Dimopoulos MA, Martínez-López J, Nagarajan C, Bal S, Costa LJ, Einsele H, Steinbrunn T, Waldschmidt JM, Riedhammer C, Banerjee R, Chng WJ, Tso A, Lin Y, Martin T, Mian H.   +30 more
europepmc   +1 more source

FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial. [PDF]

Nat Med
Cohen AD, Richter J, Trudel S, Lesokhin A, Laubach JP, Thomas SK, Harrison SJ, Costa LJ, Spencer A, Fonseca R, Forsberg PA, Berdeja JG, Kaedbey R, Bahlis NJ, Rodriguez-Otero P, Mateos MV, Tyagi T, Samineni D, Liu W, Nakamura R, Choeurng V, Wong C, Cooper J, Krishnan A.   +23 more
europepmc   +1 more source

Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium. [PDF]

Blood Cancer J
Portuguese AJ, Davis JA, Raza S, Castaneda Puglianini O, Freeman C, Alsina M, Wright C, Blue BJ, Baz RC, Shain KH, Goel U, Khouri J, Anwer F, Ali HM, Pasvolsky O, Gaballa M, Patel K, Garcia-Pleitez H, Mikulski D, Fogel L, Zolotov E, Sannareddy A, Afrough A, Anderson LD, Julian K, Dima D, Banerjee R, Liang EC, Cassano Cassano R, Herr MM, Hassan H, Shune L, Kort J, Midha S, Nadeem O, Sidana S, Lin Y, Locke FL, Hansen DK, Sborov D, Biran N, Grajales-Cruz A.   +41 more
europepmc   +1 more source